Samsung Electronics Chairman Lee Jae-yong visited the company's Seoul R&D campus and inspected the Robotics Experience (RX) business division for the first time since its establishment in July, reviewing progress in humanoid robot arm and dexterous hand technologies planned for display at CES 2027.
Kevin Weil, former science lead at OpenAI, has founded AI startup Warp Sciences, which focuses on using robots to automate wet-lab work for drug discovery. The company has raised $215 million at an $865 million valuation, in a round led by Lightspeed with participation from IVP, Mayfield, Lux Capital, Premji Invest, and Menlo Ventures.
On Oct. 14, Vir Biotechnology announced a collaboration agreement with Gilead Sciences worth up to $1.88 billion to explore and develop new cancer treatments for solid tumors. Vir will receive a $90 million upfront payment and up to $45 million in near-term preclinical milestones, and will use its PRO-XTEN masking technology and dAIsy AI platform to design drug candidates.
Colossal Biosciences has launched GenoMorph, an AI platform that combines 3D morphology, comparative genomics, and developmental biology to identify editable genes in projects with limited genetic data, supporting de-extinction efforts such as the revival of the dodo. The platform was built over more than a year using developmental data from chickens, quails, ducks, and pigeons, along with genetic and skull data from over 70 bird species.